Category Archives: Healthcare

Adverum Biotechnologies (ADVM) Received its Third Buy in a Row

After SunTrust Robinson and Piper Sandler gave Adverum Biotechnologies (NASDAQ: ADVM) a Buy rating last month, the company received another Buy, this time from Chardan Capital. Analyst Gbola Amusa reiterated a Buy rating on Adverum Biotechnologies today. The company’s shares

The Chief Commercial Officer of GW Pharma is Exercising Options

Today it was reported that the Chief Commercial Officer of GW Pharma (GWPH – Research Report), Darren Cline, exercised options to sell 150 GWPH shares for a total transaction value of $18.97K. Following this transaction Darren Cline’s holding in the

A Director at Digirad (NASDAQ: DRAD) is Buying Shares

Yesterday, a Director at Digirad (DRAD – Research Report), Cunnion Michael, bought shares of DRAD for $11.2K. Following this transaction Cunnion Michael’s holding in the company was increased by 49.77% to a total of $33.55K. In addition to Cunnion Michael,

Mizuho Securities Reaffirms Their Buy Rating on CytomX Therapeutics (CTMX)

In a report released yesterday, Mara Goldstein from Mizuho Securities maintained a Buy rating on CytomX Therapeutics (CTMX – Research Report), with a price target of $16.00. The company’s shares closed last Friday at $8.86. According to TipRanks.com, Goldstein is

A Director at Anthem (NYSE: ANTM) is Selling Shares

Yesterday, a Director at Anthem (ANTM – Research Report), Robert L. Dixon, sold shares of ANTM for $313.6K. In addition to Robert L. Dixon, 2 other ANTM executives reported Sell trades in the last month. See today’s analyst top recommended

Otonomy (OTIC) Initiated with a Buy at Craig-Hallum

Craig-Hallum analyst Francois Brisebois initiated coverage with a Buy rating on Otonomy (OTIC – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $2.56. According to TipRanks.com, Brisebois is ranked #2406 out